Monitoring the tissue perfusion during hemorrhagic shock and resuscitation: tissue-to-arterial carbon dioxide partial pressure gradient in a pig model
Journal of Translational Medicine volume 19, Article number: 390 (2021)
Despite much evidence supporting the monitoring of the divergence of transcutaneous partial pressure of carbon dioxide (tcPCO2) from arterial partial pressure carbon dioxide (artPCO2) as an indicator of the shock status, data are limited on the relationships of the gradient between tcPCO2 and artPCO2 (tc-artPCO2) with the systemic oxygen metabolism and hemodynamic parameters. Our study aimed to test the hypothesis that tc-artPCO2 can detect inadequate tissue perfusion during hemorrhagic shock and resuscitation.
This prospective animal study was performed using female pigs at a university-based experimental laboratory. Progressive massive hemorrhagic shock was induced in mechanically ventilated pigs by stepwise blood withdrawal. All animals were then resuscitated by transfusing the stored blood in stages. A transcutaneous monitor was attached to their ears to measure tcPCO2. A pulmonary artery catheter (PAC) and pulse index continuous cardiac output (PiCCO) were used to monitor cardiac output (CO) and several hemodynamic parameters. The relationships of tc-artPCO2 with the study parameters and systemic oxygen delivery (DO2) were analyzed.
Hemorrhage and blood transfusion precisely impacted hemodynamic and laboratory data as expected. The tc-artPCO2 level markedly increased as CO decreased. There were significant correlations of tc-artPCO2 with DO2 and COs (DO2: r = − 0.83, CO by PAC: r = − 0.79; CO by PiCCO: r = − 0.74; all P < 0.0001). The critical level of oxygen delivery (DO2crit) was 11.72 mL/kg/min according to transcutaneous partial pressure of oxygen (threshold of 30 mmHg). Receiver operating characteristic curve analyses revealed that the value of tc-artPCO2 for discrimination of DO2crit was highest with an area under the curve (AUC) of 0.94, followed by shock index (AUC = 0.78; P < 0.04 vs tc-artPCO2), and lactate (AUC = 0.65; P < 0.001 vs tc-artPCO2).
Our observations suggest the less-invasive tc-artPCO2 monitoring can sensitively detect inadequate systemic oxygen supply during hemorrhagic shock. Further evaluations are required in different forms of shock in other large animal models and in humans to assess its usefulness, safety, and ability to predict outcomes in critical illnesses.
Hemorrhagic shock is a life-threatening condition, with a significant loss of intravascular volume, decreased cardiac output (CO), decreased tissue perfusion pressure, and cellular hypoxia, resulting in multiple organ damage and death [1, 2]. The ultimate goal of resuscitation for hemorrhagic shock is the rapid control of the source and the restoration of effective tissue perfusion, oxygenation, and cellular metabolism . Thus, prompt assessment of the adequacy of tissue perfusion is essential for the early identification and intervention of hemorrhagic shock.
The pulmonary artery catheter (PAC) provides continuous monitoring of comprehensive hemodynamic parameters, including stroke volume, CO, mixed venous oxygen saturation, and intracardiac pressure, with several additional calculated variables to guide diagnosis and treatment . The pulse index continuous cardiac output (PiCCO) is another efficient and advanced hemodynamic monitoring system that integrates various hemodynamic variables through intra-arterial and central venous catheterization . However, these techniques are invasive, with no clear evidence of improved outcomes associated with their use to guide therapy [5, 6].
Monitoring of transcutaneous partial pressure of oxygen (tcPO2) and carbon dioxide (tcPCO2), which can non-invasively assess arterial partial pressure of oxygen (artPO2) and carbon dioxide (artPCO2), respectively, has been investigated for several decades [7,8,9,10,11,12,13,14,15]. However, in clinical practice, adherence to their use remains low . Both measures are indicators of tissue perfusion adequacy during shock [7, 12, 16, 17]. During low-flow shock, tcPO2 can detect tissue hypoxia or inadequate perfusion [18, 19]. In particular, tcPCO2 and artPCO2 mismatch and decoupling occurs during shock states , and increased tcPCO2 is associated with poor outcomes in critically ill patients [12, 21]. These observations suggest that the gradient between tcPCO2 and artPCO2 (tc-artPCO2) measured in a minimally invasive manner (i.e., with only arterial puncture needed), is useful as a rapid and accurate measurement during shock.
Despite much evidence supporting the monitoring of the divergence of tcPCO2 from artPCO2 as an indicator of the shock status, data are limited on the systemic oxygen metabolism and hemodynamic parameters, which can be obtained by PAC or PiCOO in shock states. In this study, we tested the hypotheses that (1) significant associations between tc-artPCO2 and various hemodynamic parameters of PAC or PiCCO exist and (2) tc-artPCO2 could be an early and sensitive method to detect inadequate tissue perfusion in a pig model of progressive hemorrhage shock and resuscitation.
The experimental procedures were approved by the ethics committee for animal experiments at Rakuno Gakuen University (Protocol Number: VH19B14). Care and handling of the animals were performed in accordance with the guidelines of the National Institutes of Health.
All studies were performed by a qualified and experienced research team using female pigs (Landrace × Large White × Duroc [LWD], weighing 29–34 kg). Food was withheld from the animals for 12 h before the start of the experiment; however, water was allowed 6 h prior. After getting used to the environment and following physical examination by a veterinarian, the animals were sedated by an intramuscular injection of medetomidine hydrochloride (40.0 μg/kg), midazolam (0.2 mg/kg), and butorphanol tartrate (0.2 mg/kg). Tracheal intubation was performed after induction of anesthesia using propofol, and general anesthesia was maintained with inhaled 2.0% sevoflurane (Sevoflo®, Dainippon-Sumitomo Pharma, Osaka, Japan). Anesthetics were adapted if the depth of anesthesia was insufficient. Following anesthesia induction, the pigs were placed in a supine position and administered a fluid infusion of lactated Ringer’s solution (LR, Terumo Co., Tokyo, Japan) at 10 mL/kg/h, through a 22-gauge catheter (Supercath, Medikit Co., Tokyo, Japan) placed in the right marginal ear vein. All animals were mechanically ventilated in volume-control mode (Flow-i, Maquet, Sonia, Sweden) after intravenous administration of 2 mg/kg vecuronium (Musculate®, Fuji Pharma Co., Tokyo, Japan), followed by a constant-rate infusion at 0.1 mg/kg/h, administered through the left marginal ear vein. The ventilation settings were 8–10 mL/kg tidal volume with a respirator, with positive end-expiratory pressure set at 5 cm H2O. The fraction of inspired oxygen (FIO2) was set at 0.5, with an inspiration to expiration ratio of 1:2; the respiratory rate was adjusted to 16–20/min to maintain artPCO2 50 ± 5 mmHg. Body temperature was maintained at 37.0 °C ± 0.5 °C using a heating pad.
After each catheterization was completed, all animals were allowed to stabilize for 30 min, and each initial value was regarded as the baseline value. To induce a progressive hemorrhagic shock status, blood was withdrawn from the central venous catheter and stored in sterile bags with a volume of citrate–phosphate-dextrose-adenine (CPDA-1) appropriate for 30 mL/kg of blood (14 mL CPDA-1 per 100 mL of blood). Blood withdrawal (BW) was performed three times by each 10 mL/kg, and a total of 30 mL/kg was collected. The measurement points where the loss of circulating blood volume reached 10, 20, and 30 mL/kg were defined as BW10, BW20, and BW30, respectively. Next, the animals were resuscitated by transfusing them with the stored blood. Blood transfusion (BT) was performed at intervals of 10 mL/kg, transfusing 30 mL/kg in total. The points where the gain of circulation blood volume reached 10, 20, and 30 mL/kg were defined as BT10, BT20, and BT 30, respectively (Fig. 1). Before each measurement, the animals were allowed to stabilize for 10 min.
A 7-Fr PAC (Edward Lifesciences, Irvine, CA, USA) was inserted into the left internal jugular vein and advanced into the pulmonary artery. Assessment of pulmonary artery pressure and wedge waveforms confirmed the correct position of the PAC. Simultaneously, the right femoral artery was catheterized with a thermistor-tipped 4-Fr PiCCO catheter (PV2014L16, Pulsion Medical Systems AG, Munich, Germany) connected to the PulsioFlex platform (Pulsion Medical System, Munich, Germany). Arterial blood pressure was measured via the femoral artery using a PiCCO catheter. A 6-Fr double-lumen central venous catheter (UK catheter kit UB-0610-W, 21G, 10 cm, Unitika Medical, Osaka, Japan) was inserted into the right jugular vein and positioned at the cranial end of the superior vena cava for blood withdrawal and transfusion. The distal ports of the PAC were connected to the PulsioFlex monitor sensor for the same time as for the measurement of CO via an injection of ice-cold physiological saline 0.9% (Isotonic Sodium Chloride Solution®). All transducers were zeroed and positioned at the level of the right atrium.
Transcutaneous CO2 and O2 measurements
The transcutaneous monitoring system (TCM4; Radiometer, Copenhagen, Denmark) provides non-invasive and continuous measurement of tcPO2 and tcPCO2. Prior to the fixation of transcutaneous sensor (tc Sensor 84; Radiometer, Copenhagen, Denmark), the skin was cleaned, and an adhesive ring with two drops of contact gel was applied, according to the manufacturer’s instructions. Measurements were performed with the animals in the supine position with a skin probe positioned on the right ear. Calibration was conducted automatically, with the temperature of the skin probe set at 44 °C. The tcPCO2 and tcPO2 values were obtained and recorded before CO measurement, during each hemodynamic stage, by an investigator blinded to the experiments.
Measurements of hemodynamic parameters
CO was measured by pulmonary artery thermodilution (COPATD: using PAC) and transpulmonary thermodilution (COTPTD: using PulsioFlex); 10 mL of ice-cold physiological saline 0.9% (Isotonic Sodium Chloride Solution®) was used as an indicator and was injected through the left distal port of PAC. PATD and TPTD were measured simultaneously at each time point by the same operator (YE), who was blinded to the transcutaneous CO2 and O2 measurements and laboratory data. To unify the COTPTD measurement method and eliminate the nominative effects, COTPTD was measured by the following methods: (1) each measurement was triplicated, and the averaged values of measurements were used for the analyses, (2) the indicator was injected by the same operator (YE) throughout the overall study period, (3) ΔT in TPTD (the change in blood temperature after indicator injection) was recorded; optimal = ΔT > 0.3, good = ΔT > 0.2, and bad = ΔT < 0.2, to verify the reliability of the measurement method, and (4) the indicator was injected exactly for 2–3 s (to avoid faster or slower injection); and (5) the temperature of the indicator was accurately controlled at 0 °C using an ice and cooler box. In this study, ΔT > 0.3 occurred 38 times, ΔT > 0.2 occurred 4 times, and ΔT < 0.2 did not occur at all, indicating that TPTD at all measurement points was quite accurate according to the TPTD instruction.
Hemodynamic parameters measured by PAC (pulmonary artery thermodilution [PATD]) included the central venous pressure (CVP), pulmonary artery wedge pressure (PAWP), stroke volume (SVPATD), and CO (COPATD). Transpulmonary thermodilution [TPTD] parameters obtained by PiCCO technology (Pulsion Medical System, Munich, Germany) included the mean arterial pressure (MAP), SV (SVTPTD), CO (COTPTD), global end-diastolic blood volume (GEDV), stroke volume variation (SVV), pulse pressure variation (PPV), cardiac function index (CFI, CO/GEDV), cardiac power output (CPO, mean arterial pressure [mmHg] × CO [L/min] × Κ, where Κ = 0.0022 [a conversion factor]). The shock index (SI), defined as heart rate divided by systolic blood pressure, at each measurement point was calculated. SI of > 1.0 was indicative of worsening hemodynamic status and shock . PATD and TPTD could be measured at each time point. SVV was not observed at two time points in one pig for an unknown reason; all other hemodynamic variables displayed each value.
Additionally, a perfusion index (PI), which was derived from pulse oximetry readings (Masimo SET Radical-7TM, Masimo Inc, Irvine, CA, USA), was monitored simultaneously. The Masimo Radical-7 uses transcutaneous, multi-wavelength analysis for non-invasive measurement of arterial oxygen saturation, PI, and pleth variability index (PVI), which are measures of local blood flow. A sensor (LNOP Neo-L, Masimo Inc., Irvine, CA, USA) was attached to the tail after clipping the hair. Esophageal temperature and heart rate were also recorded (BSM-6000; Nihon Kohden Inc., Tokyo, Japan).
Arterial blood gas analysis
Arterial blood samples were withdrawn anaerobically from the PiCCO catheter and collected in a plastic syringe heparinized with 1000 U/mL of sodium heparin (Novo-heparin for injection, Mochida Pharmaceutical Co., Tokyo, Japan), using an evacuation technique to minimize sample dilution. The blood samples were analyzed by an investigator blinded to the experiments immediately after collection (< 5 min) to measure artPO2, artPCO2, hemoglobin (Hb), and lactate, using a blood gas analyzer (ABL-90 FLEX; Radiometer, Copenhagen, Denmark).
Systemic oxygen delivery
An inappropriate level of systemic oxygen delivery (DO2) capacity fails to satisfy the metabolic oxygen need in the tissue. It is well established that tissues exhibit a level of systemic DO2, known as the critical DO2 (DO2 crit), below which the extraction cannot increase sufficiently to sustain O2 uptake; O2 consumption then becomes supply-dependent [23,24,25,26]. DO2 was calculated using the following equation: DO2 (mL/kg/min) = CO × hemoglobin [Hb] × 1.36 × arterial oxygen saturation (SaO2) + (partial pressure of oxygen [PaO2] × 0.0031) . In this study, tcPO2 was used to define DO2crit since tcPO2 reflects tissue oxygenation under experimental conditions. Given that the lowest baseline tcPO2 associated with survival was 28 mmHg , the lowest threshold for tcPO2 was set as 30 mmHg. This is consistent with previous studies, which demonstrated that tcPO2 values < 25 mmHg reflects a 50% decrease in oxygen consumption, preceding cardiac arrest , and that a tcPO2 value of 40 mmHg is a critical artPO2 in the subcutaneous tissue [30, 31].
Values are expressed as mean ± standard error of the mean. An unpaired two-tailed Student’s t-test or Mann–Whitney U test was performed to compare two independent groups, as appropriate. Linear regression and Bland–Altman analyses were performed to determine the correlation between tcPCO2 and artPCO2. Repeated one-way analysis of variance (ANOVA) followed by Dunnett's correction and Friedman test followed by Dunn's correction were performed for post-hoc comparisons of normally and non-normally distributed data, respectively. Spearman's correlation coefficients (r) were calculated to evaluate the correlation between any two parameters. To examine the accuracy of tc-artPCO2, SI, and arterial lactate for predicting DO2crit, receiver operating characteristic (ROC) curve analyses were performed. The area under the curve (AUC) between two pairs of potential predictors was compared using a nonparametric test. Statistical significance was defined as a two-sided p-value of < 0.05. All statistical analyses were performed using GraphPad Prism version 8.3.0 (GraphPad Software, San Diego, CA, USA) and Microsoft Excel (Microsoft 365, Microsoft Corporation, Redmond, WA, USA).
All six pigs were included, and 42 paired measurements of each of their variables were analyzed. No death occurred during the experiments.
Hemodynamics and blood gas analysis
Hemorrhage and blood transfusions impacted tc-artPCO2, MAP, heart rate, CVP, SI, PI, and comprehensive hemodynamic parameters obtained by PAC or PiCCO, such as CO and SV (Fig. 2). tc-artPCO2 increased with increased volume of blood withdrawn, whereas tc-artPCO2 decreased with increased BT volume (Fig. 2A). Hemorrhage and BTs markedly induced changes in preload parameters, such as CVP, PAWP, GEDV, SVV, PPV, and pleth variability index. Blood gas analyses showed significant changes in pH, artPO2, HCO3−, Hb, lactate, CFI, and CPO, whereas artPCO2 and base excess remained unchanged during the experiments (Fig. 3 and Table 1).
Assessment of the agreement between tcPCO2 and artPCO2
To confirm that tcPCO2 and artPCO2 are coupled in normal conditions but decoupled during hemorrhagic shock, the agreements between tcPCO2 and artPCO2 were evaluated in euvolemic or hypovolemic status. Using 12 measurement points of the euvolemic status (i.e., at BL and BT30), linear regression demonstrated that there was a strong relationship between tcPCO2 and artPCO2 (r = 0.86, P = 0.0004). In Bland–Altman analysis, the mean bias was 4.1 ± 5.4 mmHg. In contrast, using 30 measurement points of the hypovolemic status, there was no relationship between tcPCO2 and artPCO2 (r = 0.29, P = 0.11), and the mean bias based on Bland–Altman analysis was 16.2 ± 11.4 mmHg (Fig. 4).
Associations of CO with tc-artPCO2 and tcPO2
Linear regressions demonstrated significant negative correlations of tc-artPCO2 with COPATD (r = − 0.79), COTPTD (r = − 0.74), and tcPO2 (r = − 0.89) (all P < 0.0001) (Fig. 5). Data for tc-artPCO2 and tcPO2 obtained at all measurement time points were divided into four groups according to CO categories: COPATD (L/min) < 2.5, 2.5 ≤ COPATD < 3.0, 3.0 ≤ COPATD < 4.0, and 4.0 ≤ COPATD. There was a negative linear trend between tcPCO2 and CO categories: with the lowest tc-artPCO2 value (2.6 ± 1.0 mmHg) when CO was > 4.0 L/min and the highest (24.6 ± 2.9 mmHg) when CO was < 2.5 L/min. Conversely, there was a positive linear trend between tcPO2 and CO categories (Fig. 6).
Correlations between DO2 and hemodynamic variables
Compared with DO2 at baseline (15.9 ± 2.7 mL/kg/min), significant declines in DO2 at BW10, BW20, BW30, and BT10 were observed (11.2 ± 2.1, P = 0.002; 9.5 ± 2.1, P = 0.018; 7.7 ± 2.1, P = 0.002; and 11.2 ± 1.5 mL/kg/min, P = 0.04, respectively). After all the stored blood was transfused (BT30), DO2 returned to baseline value (16.2 ± 1.9 mL/kg/min). There were significant positive correlations of DO2 with tcPO2 and MAP (r = 0.72, P < 0.001; r = 0.75, P < 0.001, respectively), and significant negative correlations of DO2 with tc-artPCO2, SI, heart rate, and lactate (r = 0.77, P < 0.001; r = 0.64, P < 0.001; r = 0.30, P = 0.047; r = 0.24, P = 0.027, respectively) (Fig. 7).
Prediction of DO2crit
The critical level of DO2 (DO2crit) was calculated as 11.72 mL/kg/min, according to the predetermined tcPO2 threshold of 30 mmHg (see “Methods”). ROC curves were drawn to compare the predictive value of tc-artPCO2, SI, and lactate for DO2crit (11.72 mL/kg/min). The AUCs showed that the predictive values of tc-artPCO2, SI, and lactate were 0.94 (95% confidence interval [CI], 0.87–1.00), 0.78 (0.63–0.93), and 0.65 (0.47–0.82), respectively, with respect to the prediction of DO2crit for the transition from aerobic to anaerobic metabolism (Fig. 8A). The tc-artPCO2 cut-off of 6.15 mmHg provided the optimal sensitivity (100%) and specificity (77%) for predicting DO2crit, whereas an SI cut-off of 1.13 was identified as the optimal value (sensitivity = 70%, specificity = 82%) (Fig. 8B). The AUC for tc-artPCO2 was greater for predicting DO2crit than for predicting SI (P = 0.04) and lactate (P = 0.001) (Fig. 8B). Figure 9 shows the percentage changes in tc-artPCO2, SI, and lactate at each time point, compared with those at baseline. The largest percentage change occurred in tc-artPCO2 with hypovolemia (BW30, 353.3%) compared with SI and lactate BW30 (142.3% and 89.0%, respectively).
In this study, we assessed the usefulness of tc-artPCO2 as a rapid yet sensitive indicator of hemorrhagic shock in a mechanically ventilated pig model during progressive hemorrhagic shock and resuscitation. We verified the hypotheses that tcPCO2 can non-invasively estimate and track artPCO2 in euvolemic conditions and that tcPCO2 and artPCO2 decoupled during hemorrhagic shock. To the best of our knowledge, this study showed, for the first time, (1) strong associations of tc-artPCO2 with DO2 and CO, which were appropriately measured based on both PAC and PiCCO, and (2) significantly superior AUC for tc-artCO2, compared with those for SI or arterial lactate, which are independently associated with physiological and clinical outcomes in hemorrhagic shock [1, 22, 32,33,34]. Taken together, we conclude that tc-artCO2 reflects the variations in CO and DO2 and can be a valid, non-invasive indicator of impaired DO2 during hypovolemic shock.
The primary purpose of tcPCO2 monitoring is to measure artPCO2 non-invasively and continuously, preventing the need to perform multiple blood gas analyses and guiding therapeutic interventions. In previous studies, tcPCO2 and artPCO2 reportedly decoupled during circulatory failure and are associated with poor outcomes in critically ill patients [12, 20, 21]. Additionally, tc-artPCO2 is less invasive, rapid, and easy to use. Therefore, monitoring tcPCO2 can be used as a common utility, especially in emergency departments and intensive care units. In particular, in patients on respirator, monitoring tcPCO2 can estimate artPCO2 and detect respiratory complications as a common utility, whereas tc-artPCO2 can estimate low CO and/or low DO2 for hemodynamic and metabolic assessments during shock.
Previous studies support elevated tissue PCO2 as a marker of hypoperfusion [35,36,37,38]. The tissue hypercarbia during shock is explained by consequent reduced removal of CO2 and anaerobic production of CO2 . Current technologies allow the estimation of CO2 content in tissues (mucosal or cutaneous) based on the high diffusivity of CO2 gas. In a pig model with acute lung injury, tcPCO2 is an acceptable surrogate for artPCO2 in hemodynamically stable states; however, tcPCO2 and artPCO2 decoupled during shock . This is consistent with our results. In patients with septic shock, tcPCO2 measured from the ear lobe at study inclusion was significantly higher in patients with septic shock than in controls. Additionally, there was a significantly greater gradient between tcPCO2 and artPCO2 or end-tidal CO2 (etCO2) in patients with septic shock than in controls . Increased gastric-to-arterial PCO2 is an early indicator of circulatory failure and a prognostic factor of increased morbidity in patients with cardiopulmonary bypass after cardiac surgery . Despite these observations, the equipment for tcPCO2 is not widely used in clinical practice  and remains poorly evaluated in preclinical large animal models.
In a pig model with lethal hemorrhagic shock, Belenkiy et al. demonstrated that the non-invasive etCO2 and tcPCO2 gradient (NICO2G) could serve as a proxy for the severity of hemorrhage-induced metabolic debt, as indicated by elevated arterial lactate levels . Linear regression analyses of the parameters with lactate showed a low correlation for etCO2 (r2 = 0.26, P < 0.001); better for tcPCO2 (r2 = 0.46, P < 0.001); and best for NICO2G (r2 = 0.58, P < 0.0001). The findings that tcPCO2 increased during hemorrhage and correlated well with peripheral hypoperfusion even as artPCO2 remained constant  were consistent with our presenting results. However, etCO2 monitoring may not be suitable for serial hemodynamic assessments in patients with lung injury or under mechanical ventilation, as adjustments of respiratory setting could be frequently required. Additionally, etCO2 can be decreased in shock states because of impaired pulmonary blood flow. Thus, tc-artPCO2 adopted in our study might be more useful for detecting shock states in ventilated patients than NICO2G. Moreover, it was reported that an increase in arterial lactate occurred later than the decreases in CO and DO2 in a pig model with hemorrhagic shock due to a time difference in the occurrence of tissue and circulating lactic acid . Thus, DO2 and/or CO could be more appropriate markers for shock than lactate levels. Our efforts to measure hemodynamic parameters with two different established methods (i.e., PAC and PiCCO), and using DO2 as a primary outcome, strengthened the results of this study.
Besides tcPCO2, tcPO2 measurement allows for continuous monitoring of tissue oxygenation, which is compromised during the early phase of hemorrhagic shock and is one of the last measures to be restored during resuscitation . In this study, we further observed that tcPO2 responded rapidly to changes in CO during hemorrhage and blood transfusion (Fig. 6). Consistent with our results, previous studies using piglet models have demonstrated a rapid decrease in and restoration of tcPO2 in response to hemorrhage and fluid infusion [45, 46]. In a rat model of hemorrhagic shock and resuscitation, tcPO2 was more rapidly responsive than tcPCO2 and arterial lactate . However, in clinical practice, the dependence of tcPO2 cannot be overemphasized  because tcPO2 depends on FIO2, which should be managed frequently during critical care. Thus, tcPO2 monitoring without reference to FIO2 can be misleading .
Our study has several limitations that should be addressed in future investigations. First, the small sample size could have resulted in a type 1 error. However, to address this limitation, we have made efforts using both PAC and PiCCO systems as hemodynamic monitors for ensuring the quality of experiments. Second, this study included only female animals to minimize heterogeneity. Future studies should include both male and female animals to investigate the role of sex in susceptibility to shock. Lastly, as this study focused only on hemorrhagic shock status, our present findings cannot be extrapolated to other shock etiologies. Thus, further studies are needed to replicate these findings for all types of shocks before extrapolating the data to other critical illnesses.
Using a precise pig model, we demonstrated that continuous tc-artPCO2 monitoring is a minimally invasive technique that could be a rapid yet sensitive indicator of evolving hemorrhagic shock during mechanical ventilation and that tc-artPCO2 is superior to SI and arterial lactate levels. The present study results are encouraging, and the data clearly strengthen previous literature on techniques to monitor tissue O2 and CO2 partial pressures. Further evaluations are required in different forms of shock in other large animal models and in humans to assess its usefulness, safety, and ability to predict outcomes in critical illnesses.
Availability of data and materials
The datasets used and/or analyzed during this study are available from the corresponding author on reasonable request.
- artPCO2 :
Arterial partial pressure of carbon dioxide
- artPO2 :
Arterial partial pressure of oxygen
Cardiac function index
- COPATD :
Cardiac output measured by pulmonary artery thermodilution
- COTPTD :
Cardiac output measured by transpulmonary thermodilution
Cardiac power output
Central venous pressure
- DO2 :
- DO2crit :
- FIO2 :
Fraction of inspired oxygen
Global end-diastolic blood volume
Mean arterial pressure
Pulmonary artery catheter
Pulmonary artery pressure
Pulmonary artery wedge pressure
Pulse index continuous cardiac output
Pulse pressure variation
Pleth variability index
- SVPATD :
Stroke volume measured by pulmonary artery thermodilution
- SVTPTD :
Stroke volume measured by transpulmonary thermodilution
Stroke volume variation
- tc-artPCO2 :
Gradient between transcutaneous and arterial partial pressures of carbon dioxide
- tcPCO2 :
Transcutaneous partial pressure of carbon dioxide
- tcPO2 :
Transcutaneous partial pressure of oxygen
Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical review: hemorrhagic shock. Crit Care. 2004;8(5):373–81.
Cannon JW. Hemorrhagic shock. N Engl J Med. 2018;378(4):370–9.
Chatterjee K. The Swan-Ganz catheters: past, present, and future a viewpoint. Circulation. 2009;119(1):147–52.
Litton E, Morgan M. The PiCCO monitor: a review. Anaesth Intensive Care. 2012;40(3):393–409.
Rajaram SS, Desai NK, Kalra A, Gajera M, Cavanaugh SK, Brampton W, Young D, Harvey S, Rowan K. Pulmonary artery catheters for adult patients in intensive care. Cochrane Database Syst Rev. 2013;2:CD003408.
Zhang Z, Ni H, Qian Z. Effectiveness of treatment based on PiCCO parameters in critically ill patients with septic shock and/or acute respiratory distress syndrome: a randomized controlled trial. Intensive Care Med. 2015;41(3):444–51.
Mari A, Nougue H, Mateo J, Vallet B, Vallee F. Transcutaneous PCO2 monitoring in critically ill patients: update and perspectives. J Thorac Dis. 2019;11(Suppl 11):S1558–67.
Huttmann SE, Windisch W, Storre JH. Techniques for the measurement and monitoring of carbon dioxide in the blood. Ann Am Thorac Soc. 2014;11(4):645–52.
Binder N, Atherton H, Thorkelsson T, Hoath SB. Measurement of transcutaneous carbon dioxide in low birthweight infants during the first two weeks of life. Am J Perinatol. 1994;11(3):237–41.
Severinghaus JW. Methods of measurement of blood and gas carbon dioxide during anesthesia. Anesthesiology. 1960;21:717–26.
Mindt W, Eberhard P, Schafer R. Monitoring of PCO2 by skin surface sensors. Biotelem Patient Monit. 1982;9(1):28–35.
Tatevossian RG, Wo CC, Velmahos GC, Demetriades D, Shoemaker WC. Transcutaneous oxygen and CO2 as early warning of tissue hypoxia and hemodynamic shock in critically ill emergency patients. Crit Care Med. 2000;28(7):2248–53.
Rodriguez P, Lellouche F, Aboab J, Buisson CB, Brochard L. Transcutaneous arterial carbon dioxide pressure monitoring in critically ill adult patients. Intensive Care Med. 2006;32(2):309–12.
Bar S, Fischer MO. Regional capnometry to evaluate the adequacy of tissue perfusion. J Thorac Dis. 2019;11(Suppl 11):S1568–73.
Nassar B, Mallat J. CO2-derived variables for hemodynamic management in critically ill patients. J Thorac Dis. 2019;11(Suppl 11):S1525–7.
Vallet B, Teboul JL, Cain S, Curtis S. Venoarterial CO(2) difference during regional ischemic or hypoxic hypoxia. J Appl Physiol (1985). 2000;89(4):1317–21.
Marik PE. Regional carbon dioxide monitoring to assess the adequacy of tissue perfusion. Curr Opin Crit Care. 2005;11(3):245–51.
Wickramasinghe SN, Marjot DH, Rosalki SB, Fink RS. Correlations between serum proteins modified by acetaldehyde and biochemical variables in heavy drinkers. J Clin Pathol. 1989;42(3):295–9.
Tremper KK, Waxman K, Shoemaker WC. Effects of hypoxia and shock on transcutaneous PO2 values in dogs. Crit Care Med. 1979;7(12):526–31.
Tremper KK, Shoemaker WC. Continuous CPR monitoring with transcutaneous oxygen and carbon dioxide sensors. Crit Care Med. 1981;9(5):417–8.
Vallee F, Mateo J, Dubreuil G, Poussant T, Tachon G, Ouanounou I, Payen D. Cutaneous ear lobe Pco(2) at 37 degrees C to evaluate microperfusion in patients with septic shock. Chest. 2010;138(5):1062–70.
Allgower M, Burri C. “Shock index.” Dtsch Med Wochenschr. 1967;92(43):1947–50.
Torres Filho IP, Spiess BD, Pittman RN, Barbee RW, Ward KR. Experimental analysis of critical oxygen delivery. Am J Physiol Heart Circ Physiol. 2005;288(3):H1071-1079.
Ronco JJ, Fenwick JC, Tweeddale MG, Wiggs BR, Phang PT, Cooper DJ, Cunningham KF, Russell JA, Walley KR. Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA. 1993;270(14):1724–30.
Schumacker PT, Cain SM. The concept of a critical oxygen delivery. Intensive Care Med. 1987;13(4):223–9.
Shoemaker WC. Oxygen transport and oxygen metabolism in shock and critical illness. Invasive and noninvasive monitoring of circulatory dysfunction and shock. Crit Care Clin. 1996;12(4):939–69.
Osthaus WA, Huber D, Beck C, Roehler A, Marx G, Hecker H, Sumpelmann R. Correlation of oxygen delivery with central venous oxygen saturation, mean arterial pressure and heart rate in piglets. Paediatr Anaesth. 2006;16(9):944–7.
Yu M, Morita SY, Daniel SR, Chapital A, Waxman K, Severino R. Transcutaneous pressure of oxygen: a noninvasive and early detector of peripheral shock and outcome. Shock. 2006;26(5):450–6.
Tremper KK, Waxman K, Bowman R, Shoemaker WC. Continuous transcutaneous oxygen monitoring during respiratory failure, cardiac decompensation, cardiac arrest, and CPR. Transcutaneous oxygen monitoring during arrest and CPR. Crit Care Med. 1980;8(7):377–81.
Van Esbroeck G, Gys T, Hubens A. Evaluation of tissue oximetry in perioperative monitoring of colorectal surgery. Br J Surg. 1992;79(6):584–7.
Yu M, Chapital A, Ho HC, Wang J, Takanishi D Jr. A prospective randomized trial comparing oxygen delivery versus transcutaneous pressure of oxygen values as resuscitative goals. Shock. 2007;27(6):615–22.
Mitra B, Fitzgerald M, Chan J. The utility of a shock index >/= 1 as an indication for pre-hospital oxygen carrier administration in major trauma. Injury. 2014;45(1):61–5.
Sammour T, Kahokehr A, Caldwell S, Hill AG. Venous glucose and arterial lactate as biochemical predictors of mortality in clinically severely injured trauma patients–a comparison with ISS and TRISS. Injury. 2009;40(1):104–8.
Lavery RF, Livingston DH, Tortella BJ, Sambol JT, Slomovitz BM, Siegel JH. The utility of venous lactate to triage injured patients in the trauma center. J Am Coll Surg. 2000;190(6):656–64.
Fink MP. Tissue capnometry as a monitoring strategy for critically ill patients: just about ready for prime time. Chest. 1998;114(3):667–70.
Katsura K, Ekholm A, Siesjo BK. Tissue PCO2 in brain ischemia related to lactate content in normo- and hypercapnic rats. J Cereb Blood Flow Metab. 1992;12(2):270–80.
Knichwitz G, Rotker J, Mollhoff T, Richter KD, Brussel T. Continuous intramucosal PCO2 measurement allows the early detection of intestinal malperfusion. Crit Care Med. 1998;26(9):1550–7.
Rozenfeld RA, Dishart MK, Tonnessen TI, Schlichtig R. Methods for detecting local intestinal ischemic anaerobic metabolic acidosis by PCO2. J Appl Physiol (1985). 1996;81(4):1834–42.
Randall HM Jr, Cohen JJ. Anaerobic CO2 production by dog kidney in vitro. Am J Physiol. 1966;211(2):493–505.
Belenkiy S, Ivey KM, Batchinsky AI, Langer T, Necsoiu C, Baker W, Salinas J, Cancio LC. Noninvasive carbon dioxide monitoring in a porcine model of acute lung injury due to smoke inhalation and burns. Shock. 2013;39(6):495–500.
Lebuffe G, Decoene C, Pol A, Prat A, Vallet B. Regional capnometry with air-automated tonometry detects circulatory failure earlier than conventional hemodynamics after cardiac surgery. Anesth Analg. 1999;89(5):1084–90.
Belenkiy SM, Berry JS, Batchinsky AI, Kendrick C, Necsoiu C, Jordan BS, Salinas J, Cancio LC. The noninvasive carbon dioxide gradient (NICO2G) during hemorrhagic shock. Shock. 2014;42(1):38–43.
Shen C, Wei D, Wang G, Kang Y, Yang F, Xu Q, Xia L, Liu J. Swine hemorrhagic shock model and pathophysiological changes in a desert dry-heat environment. PLoS One. 2021;16(1):e0244727.
Maxwell TM, Lim RC Jr, Fuchs R, Hunt TK. Continuous monitoring of tissue gas tensions and pH in hemorrhagic shock. Am J Surg. 1973;126(2):249–54.
Makisalo HJ, Soini HO, Tapani Lalla ML, Hockerstedt KA. Subcutaneous and liver tissue oxygen tension in hemorrhagic shock: an experimental study with whole blood and two colloids. Crit Care Med. 1988;16(9):857–61.
Nordin A, Makisalo H, Mildh L, Hockerstedt K. Gut intramucosal pH as an early indicator of effectiveness of therapy for hemorrhagic shock. Crit Care Med. 1998;26(6):1110–7.
Venkatesh B, Morgan TJ, Lipman J. Subcutaneous oxygen tensions provide similar information to ileal luminal CO2 tensions in an animal model of haemorrhagic shock. Intensive Care Med. 2000;26(5):592–600.
We would like to thank Editage (www.editage.com) for English language editing.
This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI: 21K16596 to Dr. Endo) and internal funding.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Endo, Y., Hirokawa, T., Miyasho, T. et al. Monitoring the tissue perfusion during hemorrhagic shock and resuscitation: tissue-to-arterial carbon dioxide partial pressure gradient in a pig model. J Transl Med 19, 390 (2021). https://doi.org/10.1186/s12967-021-03060-5